The combination of BRAF and MEK inhibitors was shown to induce pyroptosis in melanoma cells via GSDME which resulted in an increase in CD4+ T cell and CD8+ T cell infiltration and a decrease in myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) (67, 68). Here, MAP2K7 is linked to melanoma.